Search the collection

2 results for Cremolini,+Chiara,+MD

Sort by:

Sort by

Limit results to:

20 per page

2 results for Cremolini,+Chiara,+MD

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-l...
Author / Creator:Cremolini, Chiara, MD ; Loupakis, Fotios, PhD ; Antoniotti, Carlotta, MD ; Lupi, Cristiana, BSc ; Sensi, Elisa, PhD ; Lonardi, Sara, MD ; Mezi, Silvia, MD ; Tomasello, Gianluca, MD ; Ronzoni, Monica, MD ; Zaniboni, Alberto, MD ; Tonini, Giuseppe, Prof ; Carlomagno, Chiara, PhD ; Allegrini, Giacomo, MD ; Chiara, Silvana, MD ; D'Amico, Mauro, MD ; Granetto, Cristina, MD ; Cazzaniga, Marina, MD ; Boni, Luca, MD ; Fontanini, Gabriella, Prof ; Falcone, Alfredo, Prof
Publisher:England: Elsevier Limited
Journal title:The lancet oncology, 2015-10, Vol.16 (13), p.1306-1315
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial
Author / Creator:Masi, Gianluca, Dr ; Loupakis, Fotios, MD ; Salvatore, Lisa, MD ; Fornaro, Lorenzo, MD ; Cremolini, Chiara, MD ; Cupini, Samanta, MD ; Ciarlo, Andrea, MD ; Del Monte, Francesca, PhD ; Cortesi, Enrico, MD ; Amoroso, Domenico, MD ; Granetto, Cristina, MD ; Fontanini, Gabriella, Prof ; Sensi, Elisa, MD ; Lupi, Cristiana, MD ; Andreuccetti, Michele, CTA ; Falcone, Alfredo, MD
Publisher:England: Elsevier Limited
Journal title:The lancet oncology, 2010-09, Vol.11 (9), p.845-852
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Search the collection

Export record to excel

Export this record

Export record to excel

FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-l...

Export this record

Export record to excel

Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial

Refine your search